| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 1.06e-05 | 3 | 38 | 2 | GO:0150043 | |
| GeneOntologyBiologicalProcess | keratinization | 4.66e-07 | 87 | 37 | 5 | GO:0031424 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 2.10e-05 | 189 | 37 | 5 | GO:0030216 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 1.26e-04 | 870 | 37 | 8 | GO:0030855 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.45e-04 | 284 | 37 | 5 | GO:0009913 | |
| GeneOntologyBiologicalProcess | epidermis development | 1.56e-04 | 461 | 37 | 6 | GO:0008544 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.70e-04 | 11 | 37 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 2.04e-04 | 12 | 37 | 2 | GO:0070831 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 2.81e-04 | 14 | 37 | 2 | GO:2001046 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.55e-05 | 656 | 37 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.59e-05 | 658 | 37 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | laminin complex | 1.36e-04 | 10 | 37 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 4.08e-04 | 17 | 37 | 2 | GO:0098637 | |
| Domain | LCE | 3.40e-08 | 17 | 38 | 4 | PF14672 | |
| Domain | LCE | 3.40e-08 | 17 | 38 | 4 | IPR028205 | |
| Domain | EGF-like_dom | 1.02e-05 | 249 | 38 | 6 | IPR000742 | |
| Domain | LAMININ_IVB | 1.21e-05 | 3 | 38 | 2 | PS51116 | |
| Domain | Laminin_IV_B | 1.21e-05 | 3 | 38 | 2 | IPR013015 | |
| Domain | SPRR/LCE | 2.46e-05 | 28 | 38 | 3 | IPR026075 | |
| Domain | EGF_LAM_2 | 3.04e-05 | 30 | 38 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 3.04e-05 | 30 | 38 | 3 | PS01248 | |
| Domain | Laminin_EGF | 4.86e-05 | 35 | 38 | 3 | PF00053 | |
| Domain | EGF_Lam | 4.86e-05 | 35 | 38 | 3 | SM00180 | |
| Domain | Laminin_EGF | 6.24e-05 | 38 | 38 | 3 | IPR002049 | |
| Domain | EGF | 1.08e-04 | 235 | 38 | 5 | SM00181 | |
| Domain | EGF_1 | 1.58e-04 | 255 | 38 | 5 | PS00022 | |
| Domain | EGF-like_CS | 1.77e-04 | 261 | 38 | 5 | IPR013032 | |
| Domain | EGF_2 | 1.90e-04 | 265 | 38 | 5 | PS01186 | |
| Domain | Fol_N | 2.19e-04 | 11 | 38 | 2 | IPR003645 | |
| Domain | FOLN | 2.19e-04 | 11 | 38 | 2 | SM00274 | |
| Domain | Growth_fac_rcpt_ | 2.77e-04 | 156 | 38 | 4 | IPR009030 | |
| Domain | fn3 | 3.20e-04 | 162 | 38 | 4 | PF00041 | |
| Domain | LAMININ_NTER | 4.75e-04 | 16 | 38 | 2 | PS51117 | |
| Domain | Laminin_N | 4.75e-04 | 16 | 38 | 2 | PF00055 | |
| Domain | Laminin_N | 4.75e-04 | 16 | 38 | 2 | IPR008211 | |
| Domain | LamNT | 4.75e-04 | 16 | 38 | 2 | SM00136 | |
| Domain | FN3 | 5.29e-04 | 185 | 38 | 4 | SM00060 | |
| Domain | FN3 | 6.95e-04 | 199 | 38 | 4 | PS50853 | |
| Domain | FN3_dom | 8.35e-04 | 209 | 38 | 4 | IPR003961 | |
| Domain | TSPN | 9.93e-04 | 23 | 38 | 2 | SM00210 | |
| Domain | VWA | 5.79e-03 | 56 | 38 | 2 | PF00092 | |
| Domain | Laminin_G | 6.20e-03 | 58 | 38 | 2 | IPR001791 | |
| Domain | - | 9.93e-03 | 74 | 38 | 2 | 3.40.50.410 | |
| Domain | PH | 1.12e-02 | 229 | 38 | 3 | PF00169 | |
| Domain | EGF_3 | 1.20e-02 | 235 | 38 | 3 | PS50026 | |
| Domain | VWFA | 1.21e-02 | 82 | 38 | 2 | PS50234 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.59e-07 | 129 | 30 | 6 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 2.80e-07 | 217 | 30 | 7 | M27640 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP29-1 LAMB1 CDSN PLCG1 LCE3D KRT37 LCE3A CAP1 WNT11 LCE3E LCE3C | 1.00e-04 | 1432 | 30 | 11 | M509 |
| Pathway | PID_INTEGRIN4_PATHWAY | 2.38e-04 | 11 | 30 | 2 | M158 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.89e-04 | 300 | 30 | 5 | M610 | |
| Pubmed | 2.70e-09 | 16 | 40 | 4 | 17410201 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 11350120 | ||
| Pubmed | 1.08e-08 | 22 | 40 | 4 | 15854049 | ||
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 1.31e-08 | 23 | 40 | 4 | 11698679 | |
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 11159194 | ||
| Pubmed | Fate and plasticity of the epidermis in response to congenital activation of BRAF. | 4.00e-07 | 13 | 40 | 3 | 25202828 | |
| Pubmed | 7.81e-07 | 16 | 40 | 3 | 21930775 | ||
| Pubmed | 9.06e-07 | 64 | 40 | 4 | 22261194 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 29599141 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 21876163 | ||
| Pubmed | The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins. | 1.29e-06 | 2 | 40 | 2 | 19147489 | |
| Pubmed | Insulin/IGF-1 controls epidermal morphogenesis via regulation of FoxO-mediated p63 inhibition. | 3.18e-06 | 25 | 40 | 3 | 23906066 | |
| Pubmed | 3.18e-06 | 25 | 40 | 3 | 23132931 | ||
| Pubmed | 3.60e-06 | 26 | 40 | 3 | 15454262 | ||
| Pubmed | Sequencing of laminin B chain cDNAs reveals C-terminal regions of coiled-coil alpha-helix. | 3.87e-06 | 3 | 40 | 2 | 6209134 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 19169255 | ||
| Pubmed | Psoriasis-Associated Late Cornified Envelope (LCE) Proteins Have Antibacterial Activity. | 3.87e-06 | 3 | 40 | 2 | 28634035 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 10814726 | ||
| Pubmed | 6.19e-06 | 31 | 40 | 3 | 20930145 | ||
| Pubmed | Role of mesenchymal nidogen for epithelial morphogenesis in vitro. | 7.73e-06 | 4 | 40 | 2 | 7925005 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 27048876 | ||
| Pubmed | Regulation and Function of Laminin A5 during Mouse and Human Decidualization. | 7.73e-06 | 4 | 40 | 2 | 35008625 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 29397434 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 2099832 | ||
| Pubmed | Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146). | 7.73e-06 | 4 | 40 | 2 | 24951930 | |
| Pubmed | Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. | 7.73e-06 | 4 | 40 | 2 | 16146715 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 8034675 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 9.50e-06 | 248 | 40 | 5 | 24006456 | |
| Pubmed | 1.05e-05 | 118 | 40 | 4 | 21078624 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 12743034 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 10964500 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 16041630 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 1678389 | ||
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 1.93e-05 | 6 | 40 | 2 | 23948589 | |
| Pubmed | Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells. | 1.93e-05 | 6 | 40 | 2 | 16236823 | |
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 2119632 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 1.93e-05 | 6 | 40 | 2 | 3794389 | |
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 20874775 | ||
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 1.93e-05 | 6 | 40 | 2 | 3109910 | |
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 10671376 | ||
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 2.70e-05 | 7 | 40 | 2 | 9004048 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 14557481 | ||
| Pubmed | CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins. | 2.70e-05 | 7 | 40 | 2 | 36804407 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 7921537 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 11891225 | ||
| Pubmed | Linkage of genes for laminin B1 and B2 subunits on chromosome 1 in mouse. | 3.60e-05 | 8 | 40 | 2 | 2993224 | |
| Pubmed | 5.08e-05 | 62 | 40 | 3 | 26644517 | ||
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 9373037 | ||
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 9034910 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 7.05e-05 | 11 | 40 | 2 | 21524702 | |
| Pubmed | Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. | 7.05e-05 | 11 | 40 | 2 | 11435469 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 7.05e-05 | 11 | 40 | 2 | 23472759 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | 7.84e-05 | 630 | 40 | 6 | 36949045 | |
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 8918877 | ||
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 9396756 | ||
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 26794322 | ||
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 36350252 | ||
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 12682087 | ||
| Pubmed | 1.16e-04 | 14 | 40 | 2 | 28893945 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 1.34e-04 | 15 | 40 | 2 | 12921739 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.34e-04 | 15 | 40 | 2 | 15895400 | |
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 17601529 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | 1.56e-04 | 1031 | 40 | 7 | 16710414 | |
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 1.73e-04 | 17 | 40 | 2 | 15056720 | |
| Pubmed | 1.73e-04 | 17 | 40 | 2 | 18082680 | ||
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 1.95e-04 | 18 | 40 | 2 | 23041440 | |
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 11311202 | ||
| Pubmed | 2.42e-04 | 20 | 40 | 2 | 22911573 | ||
| Pubmed | A high-resolution anatomical ontology of the developing murine genitourinary tract. | 2.67e-04 | 21 | 40 | 2 | 17452023 | |
| Pubmed | NotI flanking sequences: a tool for gene discovery and verification of the human genome. | 2.67e-04 | 21 | 40 | 2 | 12136098 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 20. | 3.05e-04 | 517 | 40 | 5 | 11780052 | |
| Pubmed | Renal collecting system growth and function depend upon embryonic γ1 laminin expression. | 3.21e-04 | 23 | 40 | 2 | 21903675 | |
| Pubmed | 4.12e-04 | 26 | 40 | 2 | 24742657 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 5.09e-04 | 135 | 40 | 3 | 28675934 | |
| Pubmed | 5.13e-04 | 29 | 40 | 2 | 22613833 | ||
| Pubmed | 6.39e-04 | 146 | 40 | 3 | 27068509 | ||
| Pubmed | 7.32e-04 | 153 | 40 | 3 | 25037231 | ||
| Pubmed | 8.83e-04 | 38 | 40 | 2 | 28218735 | ||
| Pubmed | 9.43e-04 | 167 | 40 | 3 | 22159717 | ||
| Pubmed | 9.79e-04 | 40 | 40 | 2 | 27068110 | ||
| Pubmed | 1.08e-03 | 175 | 40 | 3 | 28071719 | ||
| Pubmed | 1.12e-03 | 689 | 40 | 5 | 36543142 | ||
| Interaction | KRTAP4-1 interactions | 2.97e-09 | 31 | 38 | 5 | int:KRTAP4-1 | |
| Interaction | RGS17 interactions | 2.93e-08 | 48 | 38 | 5 | int:RGS17 | |
| Interaction | ALPP interactions | 1.08e-07 | 123 | 38 | 6 | int:ALPP | |
| Interaction | KRTAP5-2 interactions | 1.09e-07 | 62 | 38 | 5 | int:KRTAP5-2 | |
| Interaction | KRTAP5-4 interactions | 1.18e-07 | 63 | 38 | 5 | int:KRTAP5-4 | |
| Interaction | KRTAP10-11 interactions | 1.28e-07 | 64 | 38 | 5 | int:KRTAP10-11 | |
| Interaction | KRTAP5-11 interactions | 1.49e-07 | 66 | 38 | 5 | int:KRTAP5-11 | |
| Interaction | KRTAP5-3 interactions | 1.49e-07 | 66 | 38 | 5 | int:KRTAP5-3 | |
| Interaction | KRTAP5-7 interactions | 2.16e-07 | 71 | 38 | 5 | int:KRTAP5-7 | |
| Interaction | KRTAP9-3 interactions | 2.32e-07 | 140 | 38 | 6 | int:KRTAP9-3 | |
| Interaction | KRTAP12-3 interactions | 2.97e-07 | 146 | 38 | 6 | int:KRTAP12-3 | |
| Interaction | KRTAP4-5 interactions | 3.04e-07 | 76 | 38 | 5 | int:KRTAP4-5 | |
| Interaction | KRTAP9-2 interactions | 3.35e-07 | 149 | 38 | 6 | int:KRTAP9-2 | |
| Interaction | KRTAP5-8 interactions | 3.44e-07 | 8 | 38 | 3 | int:KRTAP5-8 | |
| Interaction | KRTAP4-4 interactions | 4.19e-07 | 81 | 38 | 5 | int:KRTAP4-4 | |
| Interaction | KRTAP4-11 interactions | 7.92e-07 | 92 | 38 | 5 | int:KRTAP4-11 | |
| Interaction | KRTAP5-6 interactions | 8.81e-07 | 94 | 38 | 5 | int:KRTAP5-6 | |
| Interaction | KRTAP1-3 interactions | 1.16e-06 | 184 | 38 | 6 | int:KRTAP1-3 | |
| Interaction | KRTAP9-8 interactions | 1.20e-06 | 100 | 38 | 5 | int:KRTAP9-8 | |
| Interaction | KRTAP17-1 interactions | 1.97e-06 | 48 | 38 | 4 | int:KRTAP17-1 | |
| Interaction | KRTAP1-5 interactions | 1.97e-06 | 48 | 38 | 4 | int:KRTAP1-5 | |
| Interaction | SPRY1 interactions | 2.01e-06 | 111 | 38 | 5 | int:SPRY1 | |
| Interaction | KRTAP5-9 interactions | 2.05e-06 | 203 | 38 | 6 | int:KRTAP5-9 | |
| Interaction | RGS20 interactions | 2.72e-06 | 118 | 38 | 5 | int:RGS20 | |
| Interaction | KRTAP4-2 interactions | 4.71e-06 | 132 | 38 | 5 | int:KRTAP4-2 | |
| Interaction | EFEMP2 interactions | 5.46e-06 | 136 | 38 | 5 | int:EFEMP2 | |
| Interaction | KRTAP10-9 interactions | 5.51e-06 | 241 | 38 | 6 | int:KRTAP10-9 | |
| Interaction | LCE2A interactions | 8.51e-06 | 69 | 38 | 4 | int:LCE2A | |
| Interaction | KRTAP10-1 interactions | 9.69e-06 | 153 | 38 | 5 | int:KRTAP10-1 | |
| Interaction | CHIC2 interactions | 1.07e-05 | 73 | 38 | 4 | int:CHIC2 | |
| Interaction | KRTAP10-5 interactions | 1.20e-05 | 160 | 38 | 5 | int:KRTAP10-5 | |
| Interaction | KRTAP4-12 interactions | 1.24e-05 | 161 | 38 | 5 | int:KRTAP4-12 | |
| Interaction | KRTAP3-2 interactions | 1.46e-05 | 79 | 38 | 4 | int:KRTAP3-2 | |
| Interaction | LCE2B interactions | 1.61e-05 | 81 | 38 | 4 | int:LCE2B | |
| Interaction | KRTAP10-7 interactions | 1.67e-05 | 293 | 38 | 6 | int:KRTAP10-7 | |
| Interaction | KRTAP3-3 interactions | 1.69e-05 | 82 | 38 | 4 | int:KRTAP3-3 | |
| Interaction | PDGFA interactions | 2.95e-05 | 32 | 38 | 3 | int:PDGFA | |
| Interaction | KRTAP2-3 interactions | 3.02e-05 | 95 | 38 | 4 | int:KRTAP2-3 | |
| Interaction | CYP21A2 interactions | 3.25e-05 | 33 | 38 | 3 | int:CYP21A2 | |
| Interaction | KRTAP2-4 interactions | 3.85e-05 | 101 | 38 | 4 | int:KRTAP2-4 | |
| Interaction | SPRY3 interactions | 3.88e-05 | 35 | 38 | 3 | int:SPRY3 | |
| Interaction | HOXA1 interactions | 4.99e-05 | 356 | 38 | 6 | int:HOXA1 | |
| Interaction | ADAMTSL4 interactions | 5.19e-05 | 217 | 38 | 5 | int:ADAMTSL4 | |
| Interaction | KRTAP1-1 interactions | 5.43e-05 | 219 | 38 | 5 | int:KRTAP1-1 | |
| Interaction | PCSK5 interactions | 5.77e-05 | 112 | 38 | 4 | int:PCSK5 | |
| Interaction | VWC2L interactions | 5.82e-05 | 40 | 38 | 3 | int:VWC2L | |
| Interaction | KRTAP10-8 interactions | 9.63e-05 | 401 | 38 | 6 | int:KRTAP10-8 | |
| Interaction | TSPAN4 interactions | 1.36e-04 | 53 | 38 | 3 | int:TSPAN4 | |
| Interaction | TRIM42 interactions | 1.74e-04 | 149 | 38 | 4 | int:TRIM42 | |
| Interaction | VWC2 interactions | 2.17e-04 | 62 | 38 | 3 | int:VWC2 | |
| Interaction | KRTAP6-3 interactions | 2.34e-04 | 161 | 38 | 4 | int:KRTAP6-3 | |
| Interaction | OIT3 interactions | 2.49e-04 | 65 | 38 | 3 | int:OIT3 | |
| Interaction | MACO1 interactions | 3.22e-04 | 175 | 38 | 4 | int:MACO1 | |
| Interaction | FIBIN interactions | 3.24e-04 | 71 | 38 | 3 | int:FIBIN | |
| Interaction | CYSRT1 interactions | 3.57e-04 | 511 | 38 | 6 | int:CYSRT1 | |
| Interaction | OGN interactions | 3.58e-04 | 15 | 38 | 2 | int:OGN | |
| Interaction | LCE2D interactions | 3.66e-04 | 74 | 38 | 3 | int:LCE2D | |
| Interaction | PLSCR2 interactions | 4.09e-04 | 16 | 38 | 2 | int:PLSCR2 | |
| Interaction | LCE4A interactions | 4.60e-04 | 80 | 38 | 3 | int:LCE4A | |
| Interaction | LYZL2 interactions | 5.49e-04 | 85 | 38 | 3 | int:LYZL2 | |
| Interaction | LCE2C interactions | 6.08e-04 | 88 | 38 | 3 | int:LCE2C | |
| Interaction | KRTAP10-6 interactions | 6.08e-04 | 88 | 38 | 3 | int:KRTAP10-6 | |
| Interaction | NOTCH2NLA interactions | 7.07e-04 | 381 | 38 | 5 | int:NOTCH2NLA | |
| Interaction | CCR9 interactions | 7.11e-04 | 21 | 38 | 2 | int:CCR9 | |
| Interaction | DEFA1 interactions | 8.82e-04 | 100 | 38 | 3 | int:DEFA1 | |
| Interaction | NBPF19 interactions | 9.44e-04 | 233 | 38 | 4 | int:NBPF19 | |
| Interaction | ATXN7 interactions | 1.13e-03 | 109 | 38 | 3 | int:ATXN7 | |
| Interaction | COL20A1 interactions | 1.18e-03 | 27 | 38 | 2 | int:COL20A1 | |
| Interaction | MDFI interactions | 1.21e-03 | 430 | 38 | 5 | int:MDFI | |
| Interaction | PLA2G10 interactions | 1.26e-03 | 113 | 38 | 3 | int:PLA2G10 | |
| Interaction | LAMA5 interactions | 1.39e-03 | 117 | 38 | 3 | int:LAMA5 | |
| Interaction | EFEMP1 interactions | 1.60e-03 | 123 | 38 | 3 | int:EFEMP1 | |
| Interaction | KRTAP9-4 interactions | 1.76e-03 | 33 | 38 | 2 | int:KRTAP9-4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 2.63e-05 | 404 | 40 | 5 | chr1q21 | |
| Cytoband | 20q13.33 | 4.63e-05 | 79 | 40 | 3 | 20q13.33 | |
| Cytoband | 1q21.3 | 1.49e-04 | 117 | 40 | 3 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q13 | 4.95e-04 | 422 | 40 | 4 | chr20q13 | |
| Cytoband | 1q21 | 2.89e-03 | 91 | 40 | 2 | 1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 8.09e-03 | 473 | 40 | 3 | chr17q21 | |
| GeneFamily | Late cornified envelope proteins | 1.61e-08 | 18 | 29 | 4 | 627 | |
| GeneFamily | Fibronectin type III domain containing | 1.18e-04 | 160 | 29 | 4 | 555 | |
| GeneFamily | Laminin subunits | 1.62e-04 | 12 | 29 | 2 | 626 | |
| GeneFamily | Collagens | 2.46e-03 | 46 | 29 | 2 | 490 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.28e-03 | 206 | 29 | 3 | 682 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 1.30e-05 | 200 | 40 | 5 | M5237 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_C | 2.94e-05 | 116 | 40 | 4 | M16130 | |
| Coexpression | NABA_CORE_MATRISOME | 5.48e-05 | 270 | 40 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 5.97e-05 | 275 | 40 | 5 | M5884 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON | 7.82e-05 | 149 | 40 | 4 | M18973 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 1.24e-04 | 11 | 40 | 2 | M566 | |
| CoexpressionAtlas | tonsil | 1.33e-05 | 182 | 36 | 5 | tonsil | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.85e-07 | 181 | 40 | 5 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.18e-07 | 183 | 40 | 5 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.52e-07 | 185 | 40 | 5 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.69e-07 | 186 | 40 | 5 | 2fdd0a80ad31cf017aafcf5dcf760ebd786b98c1 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.44e-07 | 190 | 40 | 5 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.44e-07 | 190 | 40 | 5 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.44e-07 | 190 | 40 | 5 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Metaplastic_Carcinoma-2|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.41e-06 | 92 | 40 | 4 | cad8b1b74a412988b2ae4f6126b2186100a2cdc2 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 167 | 40 | 4 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.58e-05 | 169 | 40 | 4 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-6|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.62e-05 | 170 | 40 | 4 | 3dba3f810fbd1eadf446b52e4c9c971d362a80e1 | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 1.69e-05 | 172 | 40 | 4 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.89e-05 | 177 | 40 | 4 | 8c78f7de091f16e86e326a73c9f1429e0232821f | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.94e-05 | 178 | 40 | 4 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.98e-05 | 179 | 40 | 4 | df6d2cdc4e204ce1a4628dc71dfbc5e6c6309b2a | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.11e-05 | 182 | 40 | 4 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.11e-05 | 182 | 40 | 4 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.11e-05 | 182 | 40 | 4 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | wk_15-18-Epithelial-PNS-Early_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.16e-05 | 183 | 40 | 4 | 7e8366ec8117d36cec67f77dcb0e9a6032d87fcb | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.16e-05 | 183 | 40 | 4 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.16e-05 | 183 | 40 | 4 | 9dfb398b9995d562864fe688861a831ada0814cd | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.25e-05 | 185 | 40 | 4 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.25e-05 | 185 | 40 | 4 | 512f489daeb3b72d4578dc6f4d0ebb5f38d5bbab | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Neurod2-Excitatory_Neuron.Slc17a7.Neurod2-C1ql3_(Nucleus_of_the_lateral_olfactory_tract_(LOT))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.26e-05 | 61 | 40 | 3 | a9f5cbbe5683f2574130ffe8d375d693b9aa8f2d | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Neurod2-Excitatory_Neuron.Slc17a7.Neurod2-C1ql3_(Nucleus_of_the_lateral_olfactory_tract_(LOT))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.26e-05 | 61 | 40 | 3 | 3797e1e122818211664847bb54730034af61430e | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.30e-05 | 186 | 40 | 4 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.30e-05 | 186 | 40 | 4 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.35e-05 | 187 | 40 | 4 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.35e-05 | 187 | 40 | 4 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 188 | 40 | 4 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.50e-05 | 190 | 40 | 4 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 191 | 40 | 4 | 8597a8af294f24496c317d995f07eb5dcc25c13c | |
| ToppCell | wk_15-18-Epithelial-PNS|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.66e-05 | 193 | 40 | 4 | ca65f8f93058ad50d89e69e06c10deeb46dbfc87 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.66e-05 | 193 | 40 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 194 | 40 | 4 | 80be44e9ddd9f6ddd9dff7cba0eb457431204c2d | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 195 | 40 | 4 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 195 | 40 | 4 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-05 | 195 | 40 | 4 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 195 | 40 | 4 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.82e-05 | 196 | 40 | 4 | 80264c2fbd94418f981085fed7c5bdda1e6f404c | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 196 | 40 | 4 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 196 | 40 | 4 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | wk_08-11-Epithelial-PNS|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.88e-05 | 197 | 40 | 4 | ce3f9feb6935f0e9daf13673b0a0d6e92817e187 | |
| ToppCell | Parenchyma_COVID-19|World / Sample group, Lineage and Cell type | 2.94e-05 | 198 | 40 | 4 | 45ab554e6d0399b3182f089a25b2adf96de1144b | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.00e-05 | 199 | 40 | 4 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.00e-05 | 199 | 40 | 4 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.05e-05 | 200 | 40 | 4 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.05e-05 | 200 | 40 | 4 | c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.05e-05 | 200 | 40 | 4 | 25d3865aa2ced11a5ed40013e83b47d942fdf582 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.05e-05 | 200 | 40 | 4 | 137f8f9d255c66336d4f8b44b2e3f3de721f2bf0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.05e-05 | 200 | 40 | 4 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Metaplastic_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.57e-05 | 71 | 40 | 3 | ab476ee0b91d91d44d4324da18e2e7938bba3d2c | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.25e-04 | 132 | 40 | 3 | 6a6718582edfc59c63f2c8f753be81e0f4a7246b | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.25e-04 | 132 | 40 | 3 | 780a391924f776dc6fbe44ddcf4ae0583a1e2157 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.41e-04 | 135 | 40 | 3 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.41e-04 | 135 | 40 | 3 | 366a417f9ef7c0d86e9f262d97bf788f478315ee | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.15e-04 | 148 | 40 | 3 | c95a732163050cfb5d604c2a4c9eb1afa9f19a95 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 152 | 40 | 3 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.47e-04 | 153 | 40 | 3 | 61fe71e32fc9c8cad875bc087aad0b0ff680bf45 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.68e-04 | 156 | 40 | 3 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.75e-04 | 157 | 40 | 3 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.75e-04 | 157 | 40 | 3 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-04 | 157 | 40 | 3 | c779a53b2c67d566f5d417e753cd17196a6bfd1c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-04 | 164 | 40 | 3 | 43630a448f4369fa9e4e3eccdf3b9f29cec16c39 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.25e-04 | 164 | 40 | 3 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-04 | 164 | 40 | 3 | 108fbecb56d69a675d6ce6e826a873ae528f2fd7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-04 | 164 | 40 | 3 | 46208f18325976c89f572f6627aea0582142b92d | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-04 | 164 | 40 | 3 | 78de403446fe0eb375c82ff1832cc5fbb8e20afa | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.49e-04 | 167 | 40 | 3 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.56e-04 | 168 | 40 | 3 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.56e-04 | 168 | 40 | 3 | aaafa7243c44e6852d92e3445335fc4a1018f416 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.72e-04 | 170 | 40 | 3 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 171 | 40 | 3 | 7ca404539344e14dcd90c746c9122f713a7db78b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 171 | 40 | 3 | ab113c8e773b0af47a87aed50e96be3ba71c3c82 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-04 | 172 | 40 | 3 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-04 | 172 | 40 | 3 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.89e-04 | 172 | 40 | 3 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.89e-04 | 172 | 40 | 3 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 4.89e-04 | 172 | 40 | 3 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.97e-04 | 173 | 40 | 3 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.97e-04 | 173 | 40 | 3 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-04 | 173 | 40 | 3 | 1cff815536f620e32b9805666e1aa711462c2d25 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-04 | 173 | 40 | 3 | 31ea04e65876c42b90245d280f0b6439bfffbace | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-interstitial_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-04 | 174 | 40 | 3 | ca0c2f42544092848541863c4a47b334e6828b8a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-04 | 174 | 40 | 3 | 33e5903adb746f693433bdca11a75c508bbf50c0 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.14e-04 | 175 | 40 | 3 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-04 | 175 | 40 | 3 | b80fe906043b3cb0b3ba761aadc9dc1c364aa1bf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-04 | 175 | 40 | 3 | 067c7d89cfdf6ebf70692df64b9b79d752f093dd | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-04 | 176 | 40 | 3 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.31e-04 | 177 | 40 | 3 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.31e-04 | 177 | 40 | 3 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.31e-04 | 177 | 40 | 3 | 15a5c96ea840376e54933ebe7a8334a11d9ce411 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-04 | 178 | 40 | 3 | 24e8c62060455159235985f456af0c5023a7f3f5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-04 | 178 | 40 | 3 | 4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 5.49e-04 | 179 | 40 | 3 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-04 | 180 | 40 | 3 | 18bf8561ad3aa9787d2a8ef942a96f641734c608 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.58e-04 | 180 | 40 | 3 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 5.58e-04 | 180 | 40 | 3 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.67e-04 | 181 | 40 | 3 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.76e-04 | 182 | 40 | 3 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| Drug | ALT-711 | 5.59e-06 | 21 | 38 | 3 | CID000216304 | |
| Disease | psoriasis | 2.24e-05 | 273 | 37 | 5 | EFO_0000676 | |
| Disease | response to olanzapine | 1.59e-04 | 15 | 37 | 2 | GO_0097333 | |
| Disease | infant head circumference | 1.59e-04 | 15 | 37 | 2 | EFO_0004577 | |
| Disease | colon carcinoma | 4.88e-04 | 26 | 37 | 2 | EFO_1001950 | |
| Disease | hair morphology | 6.08e-04 | 29 | 37 | 2 | EFO_0005038 | |
| Disease | Grey matter density measurement | 8.37e-04 | 34 | 37 | 2 | EFO_0010306 | |
| Disease | attempted suicide | 1.44e-03 | 178 | 37 | 3 | EFO_0004321 | |
| Disease | wellbeing measurement | 1.64e-03 | 692 | 37 | 5 | EFO_0007869 | |
| Disease | vitamin D measurement, COVID-19 | 1.73e-03 | 49 | 37 | 2 | EFO_0004631, MONDO_0100096 | |
| Disease | behavior | 2.18e-03 | 55 | 37 | 2 | GO_0007610 | |
| Disease | Psoriasis | 2.34e-03 | 57 | 37 | 2 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 2.34e-03 | 57 | 37 | 2 | C0030246 | |
| Disease | breast carcinoma (is_marker_for) | 3.12e-03 | 66 | 37 | 2 | DOID:3459 (is_marker_for) | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 3.40e-03 | 69 | 37 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | atopic eczema | 3.86e-03 | 252 | 37 | 3 | EFO_0000274 | |
| Disease | Hodgkins lymphoma | 4.77e-03 | 82 | 37 | 2 | EFO_0000183 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPCPDKCAAFSGTPS | 201 | Q8NDY6 | |
| AGAPPSGGSAPCSCL | 376 | Q03828 | |
| ELSGLPSGPSAGSCP | 216 | Q01518 | |
| PAPASSSSCCGSGRG | 31 | Q9UGL9 | |
| RPCSSDIPDSPCSGG | 216 | Q15517 | |
| APSDSAPGCSPCTGG | 701 | Q14644 | |
| TSALDCGSLGDCPPP | 536 | O95153 | |
| CTSCPSCGPVTGGSP | 426 | O76014 | |
| PSSCETGPGSPSGHC | 101 | Q9BUM1 | |
| GGGGSPPSSSSSSCC | 71 | Q8WY41 | |
| PPGASCSETECGGPN | 1401 | P07942 | |
| GAPGDAPCATSPCGG | 1411 | P55268 | |
| GSSSCHPCPPGTFSD | 406 | A8MWY0 | |
| ASSNPAFCGPGKPSC | 6 | Q7Z6I8 | |
| VSACSCSSETPGPPG | 1061 | Q9P218 | |
| ASPPGPCSGAACAPS | 31 | O75912 | |
| CGDSCPGSCPSLSAP | 2346 | Q9Y6R7 | |
| PGSCPSLSAPEGCES | 2351 | Q9Y6R7 | |
| GPSGQPGYCDPSSCS | 1751 | Q05707 | |
| PPASSSCAPSSGGCG | 26 | Q5TA76 | |
| PPPSSDCALSSGGCG | 31 | Q5T5A8 | |
| PPASSGCAPSSGGCG | 31 | Q9BYE3 | |
| PPASSGCAPSSGGCG | 31 | Q5T5B0 | |
| SCQPSIGAPSGCDPA | 51 | A8MX34 | |
| GGSPCSGPASETLDC | 576 | P07358 | |
| FIGPTPCPSCGSSLS | 451 | Q5VWM6 | |
| SCQGDSGGPLTCSEP | 281 | P0CW18 | |
| CSCTSGASSPPGAPG | 561 | Q9ULZ9 | |
| GAAAPSSGPGPCAAA | 26 | Q8TCU6 | |
| LPSPCDSDPCFNGGS | 541 | Q8TER0 | |
| GSTPGPCFLCGSAPG | 211 | Q96EP0 | |
| GETPPCLPGDSCSSS | 306 | Q9H2V7 | |
| SPCANGCGPGAPSDA | 6 | P19174 | |
| CPGGPSSPCSDRGVC | 1971 | Q9NY15 | |
| CSPLSSGGGAESLPP | 631 | A8K0R7 | |
| STGGCSPCSGPGPSS | 51 | Q0IIN9 | |
| TSGDLPGCSCGPVPG | 131 | O96014 | |
| GVPCSSCPPSYGGSC | 226 | O43692 | |
| ADPCSPSPGASGSAG | 2921 | Q15911 | |
| PAESPACGDCVTSPG | 86 | Q96HR8 | |
| NEGPTCPTPGCDGSG | 941 | Q01538 |